Dendritic cell-based vaccine (Baylor Research Institute)

N/A

Report date: 2024/12/11 10:31:01

Base Information

Drug NameDendritic cell-based vaccine (Baylor Research Institute)
Drug Alias NameDC-HIV LIPO-5
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBaylor Research Institute LlcAnrs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaylor Research Institute Llc
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A